Oncología Médica Traslacional y Terapia Individualizada del Cáncer

Climent, MA; Font, A; Duran, I; Puente, J; Mendez-Vidal, MJ; Saez, MI; Lobera, CS; Arija, JAA; Gonzalez-Del-Alba, A; Sanchez-Hernandez, A; Fita, MJJ; Esteban, E; Alonso-Gordoa, T; Gonzalez, BM; Maroto, P; Lazaro-Quintela, M; Cassinello-Espinosa, J; Perez-Valderrama, B; Garcias, C; Castellano, D.

A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

EUROPEAN JOURNAL OF CANCER. 2022; 175: 110-119 Nº de citas: 9 [doi:10.1016/j.ejca.2022.08.002]

Vera, R; Ibarrola-de-Andres, C; Adeva, J; Perez-Rojas, J; Garcia-Alfonso, P; Rodriguez-Gil, Y; Macarulla, T; Serrano-Pinol, T; Mondejar, R; Madrigal-Rubiales, B.

Expert consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology on the determination of biomarkers in pancreatic and biliary tract cancer

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(11): 2107-2119 Nº de citas: 3 [doi:10.1007/s12094-022-02873-0]

Lope, V; Guerrero-Zotano, A; Ruiz-Moreno, E; Bermejo, B; Antolin, S; Montano, A; Baena-Canada, JM; Vazquez, MR; de Larrea-Baz, NF; Chacon, JI; Garcia-Saenz, JA; Olier, C; Munoz, M; Anton, A; Rovira, PS; Lanza, AA; Gonzalez, S; Oltra, A; Brunet, J; Gregori, JG; Martinez, MT; Calvo, L; Rosell, L; Bezares, S; Pastor-Barriuso, R; Perez-Gomez, B; Martin, M; Pollan, M.

Clinical and Sociodemographic Determinants of Adherence to World Cancer Research Fund/American Institute for Cancer Research (WCRF/AICR) Recommendations in Breast Cancer Survivors-Health-EpiGEICAM Study

Cancers. 2022; 14(19): Nº de citas: 9 [doi:10.3390/cancers14194705]

Carmona-Bayonas, A; Verso, M; Canovas, MS; Perez, JR; de Herreros, MG; del Prado, PM; Perez, IF; Verduguez, TQ; Portero, BO; Olmos, VP; Gomez, D; Ortega, L; Moyano, MS; Brozos, EM; Biosca, M; Rebollo, MA; Sanchez, LT; Perez, CH; Buron, JDC; Lago, NM; Perez, EG; Langa, JM; Segura, PP; de Castro, EM; Jimenez-Fonseca, P; Agnelli, G; Munoz, A.

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

THROMBOSIS AND HAEMOSTASIS. 2022; 122(10): 1653-1661 Nº de citas: 2 [doi:10.1055/a-1816-8347]

Canovas, MS; Garay, DF; Moran, LO; Perez, JR; Rubio, CMG; de Mena, ML; Portero, BO; Castro, JB; Lage, Y; Lavin, DC; Blanco, ABR; de Soignie, AMMF; Perejon, JZB; Colomo, LJ; Boluda, NB; Moreno, JB; Verduguez, TQ; Garrido, CR; Huertas, RM; Puig, CFI; Martin, AJM.

Immune checkpoint inhibitors-associated thrombosis in patients with lung cancer and melanoma: a study of the Spanish society of medical oncology (SEOM) thrombosis and cancer group

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(10): 2010-2020 Nº de citas: 11 [doi:10.1007/s12094-022-02860-5]

Majem, M; Alvarez, R; Ortega, AL; de Alda, LR; Gordo, R; Garcia, JF; Ivanova-Markova, Y; Gonzalez-Dominguez, A; San Cristobal, RS; Rojo, F.

Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non-small cell lung cancer in Spain

GLOBAL & REGIONAL HEALTH TECHNOLOGY ASSESSMENT. 2022; 9: 82-90 Nº de citas: 2 [doi:10.33393/grhta.2022.2449]

Galactionova, K; Loibl, S; Salari, P; Marme, F; Martin, M; Untch, M; Bonnefoi, HR; Kim, SB; Bear, HD; McCarthy, N; Gelmon, KA; Garcia-Saenz, JA; Kelly, CM; Reimer, T; Toi, M; Rugo, HS; Gnant, M; Makris, A; Burchardi, N; Schwenkglenks, M.

Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial

Frontiers in Oncology. 2022; 12: Nº de citas: 3 [doi:10.3389/fonc.2022.886831]

Larkin J; Weber J; Del Vecchio M; Gogas H; Arance AM; Dalle S; Cowey CL; Schenker M; Grob JJ; Chiarion-Sileni V; Márquez-Rodas I; Butler MO; Di Giacomo AM; Middleton MR; De la Cruz-Merino L; Arenberger P; Atkinson V; Hill A; Fecher LA; Millward M; Khushalani NI; Queirolo P; Long GV; Lobo M; Askelson M; Ascierto PA; Mandalá M.

Adjuvant nivolumab versus ipilimumab (CheckMate 238 trial): Reassessment of 4-year efficacy outcomes in patients with stage III melanoma per AJCC-8 staging criteria

EUROPEAN JOURNAL OF CANCER. 2022; 173: 285-296 Nº de citas: 24 [doi:10.1016/j.ejca.2022.06.041]

Vazquez, JC; Pinero, A; de Castro, FJ; Lluch, A; Martin, M; Barnadas, A; Alba, E; Rodriguez-Lescure, A; Rojo, F; Gimenez, J; Sola, I; Quintana, MJ; Bonfill, X; Urrutia, G; Sanchez-Rovira, P.

The value of sentinel lymph-node biopsy after neoadjuvant therapy: an overview

CLINICAL & TRANSLATIONAL ONCOLOGY. 2022; 24(9): 1744-1754 Nº de citas: 6 [doi:10.1007/s12094-022-02824-9]

Donat-Vargas, C; Guerrero-Zotano, A; Lope, V; Bermejo, B; Casas, A; Baena-Canada, JM; Antolin, S; Sanchez-Rovira, P; Anton, A; Garcia-Saenz, JA; Ramos, M; Munoz, M; de Juan, A; Sanchez, CJ; Chacon, JI; Gil-Gil, M; Conejero, RA; Llombart, A; Bezares, S; de Larrea-Baz, NF; Perez-Gomez, B; Martin, M; Pollan, M.

Type does matter. Use VIRGIN olive oil as your preferred fat to reduce your risk of breast cancer: case-control EpiGEICAM study

EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2022; 76(9): 1343-1346 Nº de citas: 2 [doi:10.1038/s41430-022-01101-w]

Zhu, Z; Turner, NC; Loi, S; Andre, F; Martin, M; Dieras, V; Gelmon, KA; Harbeck, N; Zhang, C; Cao, JQ; Yan, ZM; Lu, DR; Wei, P; VanArsdale, TL; Rejto, PA; Huang, X; Rugo, HS; Loibl, S; Cristofanilli, M; Finn, RS; Liu, Y.

Comparative biomarker analysis of PALOMA-2/3 trials for palbociclib

npj Precision Oncology. 2022; 6(1): Nº de citas: 5 [doi:10.1038/s41698-022-00297-1]

Martin-Roman, L; Fernandez-Martinez, M; Kayser Mata, S; Colombari, R; Pascual-Espinosa, P; Rey-Valcarcel, C; Jimenez-Gomez, LM; Turegano-Fuentes, F.

Relevance of pneumoperitoneum in the conservative approach to complicated acute diverticulitis A retrospective study identifying risk factors associated with treatment failure

Minerva Surgery. 2022; 77(4): 327-334 Nº de citas: 4 [doi:10.23736/S2724-5691.21.08997-8]

Wysocki, O; Zhou, C; Rogado, J; Huddar, P; Shotton, R; Tivey, A; Albiges, L; Angelakas, A; Arnold, D; Aung, T; Banfill, K; Baxter, M; Barlesi, F; Bayle, A; Besse, B; Bhogal, T; Boyce, H; Britton, F; Calles, A; Castelo-Branco, L; Copson, E; Croitoru, A; Dani, SS; Dickens, E; Eastlake, L; Fitzpatrick, P; Foulon, S; Frederiksen, H; Ganatra, S; Gennatas, S; Glenthoj, A; Gomes, F; Graham, DM; Hague, C; Harrington, K; Harrison, M; Horsley, L; Hoskins, R; Hudson, Z; Jakobsen, LH; Joharatnam-Hogan, N; Khan, S; Khan, UT; Khan, K; Lewis, A; Massard, C; Maynard, A; McKenzie, H; Michielin, O; Mosenthal, AC; Obispo, B; Palmieri, C; Patel, R; Pentheroudakis, G; Peters, S; Rieger-Christ, K; Robinson, T; Romano, E; Rowe, M; Sekacheva, M; Sheehan, R; Stockdale, A; Thomas, A; Turtle, L; Vinal, D; Weaver, J; Williams, S; Wilson, C; Dive, C; Landers, D; Cooksley, T; Freitas, A; Armstrong, AC; Lee, RJ.

An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves

Cancers. 2022; 14(16): Nº de citas: 2 [doi:10.3390/cancers14163931]

Siles, MG; Lopez-Beltran, A; Pelechano, P; Vicente, AMG; Sarrio, RG; Pena, EGH; Antolin, AR; Zapatero, A; Arranz, JA; Climent, MA.

Advances in Transversal Topics Applicable to the Care of Bladder Cancer Patients in the Real-World Setting

Cancers. 2022; 14(16): Nº de citas: 2 [doi:10.3390/cancers14163968]

Hamilton, E; Cortes, J; Ozyilkan, O; Chen, SC; Petrakova, K; Manikhas, A; Jerusalem, G; Hegg, R; Huober, J; Zhang, W; Chen, YY; Martin, M.

nextMONARCH Phase 2 randomized clinical trial: overall survival analysis of abemaciclib monotherapy or in combination with tamoxifen in patients with endocrine-refractory HR +, HER2-metastatic breast cancer

BREAST CANCER RESEARCH AND TREATMENT. 2022; 195(1): 55-64 Nº de citas: 7 [doi:10.1007/s10549-022-06662-9]

Martin, M; Hegg, R; Kim, SB; Schenker, M; Grecea, D; Garcia-Saenz, JA; Papazisis, K; Ouyang, QC; Lacko, A; Oksuzoglu, B; Reeves, J; Okera, M; Testa, L; Shimizu, C; Denduluri, N; Adamchuk, H; Dakhil, S; Wei, R; Forrester, T; Fernandez, MM; Zimmermann, A; Headley, D; Johnston, SRD.

Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy A Prespecified Analysis of the monarchE Randomized Clinical Trial

JAMA Oncology. 2022; 8(8): 1190-1194 Nº de citas: 39 [doi:10.1001/jamaoncol.2022.1488]

Gil-Herrero, L; Pollan, M; Martin, M; Lopez-Tarruella, S; Castellanos, M; Casla-Barrio, S.

The importance of physical exercise in cardiovascular fitness in breast cancer survivors. A cross-sectional study: women in Motion 2.0

SUPPORTIVE CARE IN CANCER. 2022; 30(8): 6745-6754 Nº de citas: 7 [doi:10.1007/s00520-022-06993-9]

Escudero-Vilaplana, V; Romero-Medrano, L; Villanueva-Bueno, C; de Diago, MR; Yanez-Montesdeoca, A; Collado-Borrell, R; Campana-Montes, JJ; Marzal-Alfaro, B; Revuelta-Herrero, JL; Calles, A; Galera, M; Alvarez, R; Herranz, A; Sanjurjo, M; Artes-Rodriguez, A.

Smartphone-Based Ecological Momentary Assessment for the Measurement of the Performance Status and Health-Related Quality of Life in Cancer Patients Under Systemic Anticancer Therapies: Development and Acceptability of a Mobile App

Frontiers in Oncology. 2022; 12: [doi:10.3389/fonc.2022.880430]